Earnings calls

Jupiter Life Lin concall ledger

Every earnings call for JLHL — management tone, guidance, KPIs and promise tracking, quarter by quarter.

JLHL · 5 transcripts · Healthcare · latest Q3 FY26

Q3 FY26Published 02 Feb 2026Call held 02 Feb 2026

JLHL Q3 FY26 Earnings Call Transcript & Analysis

EBITDA₹83.4 cr+9% YoYEBITDA Margin22.8%PAT₹42.5 cr−19% YoYPAT Margin11.6%Total Income₹365.3 cr+10% YoY

EBITDA (Q3 FY26) ₹83 cr (+9% YoY); EBITDA Margin (Q3 FY26) 22.8%; PAT (Q3 FY26) ₹42 cr (−19% YoY). Dombivli hospital completed ahead of schedule and within budget (INR 425 crores capex).

Read full transcript & analysis

Q2 FY26Published 10 Nov 2025Call held 10 Nov 2025

JLHL Q2 FY26 Earnings Call Transcript & Analysis

Q2 Operating Income₹374.4 cr+12% YoYQ2 EBITDA₹85.4 cr+9% YoYQ2 EBITDA Margin22.8%Q2 PAT₹57.4 cr+11% YoYH1 Operating Income₹727.4 cr+15% YoY

Q2 Operating Income ₹374 cr (+12% YoY); Q2 EBITDA ₹85 cr (+9% YoY); Q2 EBITDA Margin 22.8%. Q2 FY26 Operating Income: ₹374.4 crores, up 11.7% YoY.

Read full transcript & analysis

Q1 FY26Published 04 Aug 2025Call held 04 Aug 2025

JLHL Q1 FY26 Earnings Call Transcript & Analysis

EBITDA₹78.1 cr+20% YoYEBITDA Margin22.5%PAT—−2% YoYPAT Margin12.6%Total Income₹347.6 cr+21% YoY

EBITDA ₹78 cr (+20% YoY); EBITDA Margin 22.5%. Total income grew 20.5% YoY to ₹347.6 crores.

Read full transcript & analysis

Q4 FY25Published 12 May 2025Call held 12 May 2025

JLHL Q4 FY25 Earnings Call Transcript & Analysis

EBITDA₹296.6 cr+23% YoYEBITDA Margin23.5%PAT₹193.5 cr

EBITDA (FY25) ₹297 cr (+22% YoY); EBITDA Margin (FY25) 23.5%; PAT (FY25) ₹194 cr. FY25 Income of ₹1,261.5 crores, up 17.5% YoY.

Read full transcript & analysis

Q3 FY25Published 07 Feb 2025Call held 07 Feb 2025

JLHL Q3 FY25 Earnings Call Transcript & Analysis

EBITDA₹76.4 cr+22% YoYEBITDA Margin23.7%PAT₹52.5 cr+20% YoY

EBITDA (Q3 FY25) ₹76 cr (+22% YoY); EBITDA Margin (Q3 FY25) 23.7%; PAT (Q3 FY25) ₹52 cr (+20% YoY). Q3 FY25 Income grew 17.7% YoY to Rs. 322 crores.

Read full transcript & analysis